Ensign Peak Advisors Inc Has $6.92 Million Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Ensign Peak Advisors Inc lessened its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 44.4% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 75,225 shares of the medical device company's stock after selling 60,000 shares during the quarter. Ensign Peak Advisors Inc's holdings in Cooper Companies were worth $6,915,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in COO. T. Rowe Price Investment Management Inc. lifted its holdings in shares of Cooper Companies by 2.1% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 7,678,965 shares of the medical device company's stock valued at $705,928,000 after buying an additional 155,233 shares during the period. JPMorgan Chase & Co. lifted its holdings in shares of Cooper Companies by 1.5% in the fourth quarter. JPMorgan Chase & Co. now owns 5,004,523 shares of the medical device company's stock valued at $460,066,000 after buying an additional 74,501 shares during the period. Geode Capital Management LLC lifted its holdings in shares of Cooper Companies by 2.3% in the fourth quarter. Geode Capital Management LLC now owns 4,906,463 shares of the medical device company's stock valued at $449,907,000 after buying an additional 109,907 shares during the period. Victory Capital Management Inc. lifted its holdings in shares of Cooper Companies by 14.6% in the fourth quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company's stock valued at $415,985,000 after buying an additional 574,899 shares during the period. Finally, Price T Rowe Associates Inc. MD lifted its holdings in shares of Cooper Companies by 517.0% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 3,529,477 shares of the medical device company's stock valued at $324,466,000 after buying an additional 2,957,421 shares during the period. Institutional investors and hedge funds own 24.39% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on COO. Robert W. Baird cut their price objective on Cooper Companies from $117.00 to $107.00 and set an "outperform" rating for the company in a report on Friday, March 7th. JPMorgan Chase & Co. cut their target price on Cooper Companies from $120.00 to $110.00 and set an "overweight" rating on the stock in a research report on Friday, March 7th. BNP Paribas raised Cooper Companies to a "hold" rating in a research report on Thursday, March 13th. Piper Sandler reaffirmed an "overweight" rating and set a $115.00 target price (down from $120.00) on shares of Cooper Companies in a research report on Friday, March 7th. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of Cooper Companies in a research report on Friday, March 7th. Four equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $110.25.

Cooper Companies Stock Up 1.8%

NASDAQ:COO traded up $1.47 during trading hours on Friday, hitting $82.92. 1,519,674 shares of the company's stock traded hands, compared to its average volume of 1,467,845. The firm has a market cap of $16.58 billion, a P/E ratio of 42.52, a P/E/G ratio of 2.25 and a beta of 1.08. The Cooper Companies, Inc. has a twelve month low of $69.81 and a twelve month high of $112.38. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The stock's fifty day moving average price is $80.19 and its two-hundred day moving average price is $90.20.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, meeting the consensus estimate of $0.92. The firm had revenue of $964.70 million for the quarter, compared to analyst estimates of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. On average, research analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.